Testosterone Therapy in High-Risk Men for Prostate Cancer

madman · Saturday at 10:28 AM

Testosterone Therapy in High-Risk Men for Prostate Cancer

A video from Edoardo Pozzi, posted on Mar 25, 2025.

www.vumedi.com

madman · Saturday at 10:30 AM

madman · Saturday at 10:31 AM

madman · Saturday at 10:33 AM

madman · Saturday at 10:35 AM

madman · Saturday at 10:39 AM

madman · Saturday at 10:45 AM

madman · Saturday at 10:48 AM

madman · Saturday at 10:53 AM

madman · Saturday at 11:06 AM

madman · Saturday at 11:07 AM

madman · Saturday at 11:13 AM

madman · Saturday at 11:14 AM

Last slide for post #12 (above)

madman · Saturday at 11:15 AM

madman · Saturday at 11:23 AM

Post in thread 'My results on daily prop 11mg SQ'

Jan 3, 2025

FunkOdyssey said:
Poor metabolic health is a major risk factor for prostate cancer, which results in high levels of insulin (one of the most potent growth factors for cancer), inflammation, etc.

Triglyceride-glucose index is a predictor of the risk of prostate cancer: a retrospective study based on a transprostatic aspiration biopsy population - PubMed

TyG index and age are risk factors for prostate cancer, and the interaction between the TyG index and different risk factors may increase the risk of prostate cancer. TyG index has some predictive value for the risk of prostate cancer, and the risk of prostate cancer can be reduced by...

pubmed.ncbi.nlm.nih.gov

TRT is not. Men with active prostate cancer are even being treated with TRT now without any adverse effects on progression or mortality:

Oncologic Outcomes of Testosterone Therapy for Men on Active Surveillance for Prostate Cancer: A Population-based Analysis - PMC

In this population-based study, testosterone therapy for men on active surveillance for prostate cancer did not worsen mortality. Keywords: Testosterone, Prostate cancer, Outcomes, Active surveillance

pmc.ncbi.nlm.nih.gov

Look into the saturation model of androgens in the prostate. It takes a very low level of serum testosterone (like serious hypogonadism) to produce intraprostate levels...

madman · Saturday at 11:24 AM

Thread 'Dr. Ahlering & Dr. Lee: Newsweek's America's Best Prostate Cancer Specialists List'

Feb 22, 2025

Congratulations to Dr. Thomas Ahlering and Dr. David Lee, both included on Newsweek and Statista's AMERICA'S BEST PROSTATE CANCER SPECIALISTS award list.

To spotlight the country's top prostate cancer specialists, Newsweek partnered with Statista for the first annual ranking of America's Best Prostate Cancer Oncologists & Surgeons.

The ranking recognizes the top 150 individuals in each of the two categories.The ranking is compiled from four sources: physician performance information based on Medicare data, an...

madman · Saturday at 11:27 AM

Thread 'TRT and the Prostate'

Mar 4, 2022

Testosterone Treatment and the Risk of Prostate Adverse Events (2022)
Jason A. Levy, DO, MS, Arthur L. Burnett, MD, MBA, Adrian S. Dobs, MD, MHS

INTRODUCTION

Definition Hypogonadism is a clinical syndrome that results from failure of the testis to produce physiologic concentrations of testosterone (T).1 Various thresholds exist to define low total T ranging from 230 to 350 ng/dL. Peak T levels typically are measured between 3 and 8 AM with total T level decreasing during the first 30 minutes of waking.2Serum T decreases with age and has shown to have an...

madman · Saturday at 11:31 AM

Post in thread 'Testosterone therapy for men diagnosed with or treated for prostate cancer .'

Dec 13, 2024

Testosterone Therapy Today: Clinical Advances & Safety with Dr. Abraham Morgentaler

Dr. Morgentaler back in action! Listen closely, loved this one! Pros/Cons oral TU (51:24-57:12) *one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits and clearly that's not true and the...

www.excelmale.com

madman · Saturday at 1:59 PM

Thread 'EAU - EANM - ESTRO -ESUR - ISUP - SIOG Guidelines on Prostate Cancer (2025)'

Saturday at 1:57 PM

* Hypogonadal men receiving testosterone supplements do not have an increased risk of developing PCa [84]. A pooled analysis showed that men with very low concentrations of free testosterone (lowest 10%) have a below average risk (OR: 0.77) of PCa [85].

3.2 Aetiology and risk factors for prostate cancer

A wide variety of endogenous and exogenous/environmental factors have been discussed as being associated with the risk of developing PCa, or as being aetiologically important for the progression from latent to clinical PCa [14]. As...